Triple-Fusion Vaccine DCSurvivin-LTB Stops TNBC Growth
In a groundbreaking development that could transform the therapeutic landscape of one of the most aggressive breast cancer subtypes, researchers have unveiled a novel triple-fusion vaccine that effectively targets survivin, a...
Read moreDetails






















